Potent inhibitor of the complement membrane attack complex (MAC) action. Acts by binding, in a species specific manner, to the C8 and/or C9 complements of the assembling MAC, thereby preventing incorporation of the multiple copies of C9 required for complete formation of the osmolytic pore. Expressed in erythrocytes and lymphocytes. Not detected in platelets.